Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
Clinical trial NCT06928922 · RECRUITING
Trial details
- NCT number
- NCT06928922
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2027-02-24
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.